Summary
Responding to reports last week that the U.S. Food and Drug Administration (FDA) had approved an additional generic for the abortion drug, mifepristone
Source: Zenit
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
